Intensive versus conventional glucose control in critically ill patients with traumatic brain injury: long-term follow-up of a subgroup of patients from the NICE-SUGAR study

@article{Finfer2009IntensiveVC,
  title={Intensive versus conventional glucose control in critically ill patients with traumatic brain injury: long-term follow-up of a subgroup of patients from the NICE-SUGAR study},
  author={Simon Finfer and Dean R. Chittock and Steve Su and Deborah Blair and Denise M Foster and Vinay K. Dhingra and Rinaldo Bellomo and Deborah Cook and Peter Dodek and William Reed Henderson and Paul C. H{\'e}bert and Stephane Heritier and Daren Keith Heyland and Colin McArthur and Ellen McDonald and Imogen Mitchell and John A. Myburgh and Robyn Norton and J. Potter and Bruce Gregory Robinson and Juan J. Ronco},
  journal={Intensive Care Medicine},
  year={2009},
  volume={41},
  pages={1037-1047}
}
To compare the effect of intensive versus conventional blood glucose control in patients with traumatic brain injury. In a large international randomized trial patients were randomly assigned to a target blood glucose (BG) range of either 4.5–6.0 mmol/L (intensive control) or <10 mmol/L (conventional control). Patients with traumatic brain injury (TBI) were identified at randomization and data were collected to examine the extended Glasgow outcome score (includes mortality) at 24 months. Of the… CONTINUE READING